Global Distribution Dopharma already maintains exclusive agents and distributors across around 70 countries and direct marketing in NL, Belgium, Romania, Germany and Lithuania. This network can be leveraged to rapidly introduce new product lines through existing partners, reducing entry costs and time to market.

Swine Opportunity The launch of Y-D-Fix for farrowing and weaning highlights a focus on swine health and nutrition. There is potential to expand with complementary swine-focused products, vaccines, and farm-management solutions sold via the current pig-focused channels across Europe.

Market Access Dopharma’s in-house R&D and regulatory affairs capabilities, plus the international arm that manages non-domestic activities, position the company to offer regulatory support and market access services to new markets and partners seeking EU entry.

Mid-market Focus With a mid-sized footprint and leadership in the Dutch antimicrobial segment, the company can target mid-sized veterinary practices and regional wholesalers with high-margin specialties such as analgesics, anaesthetics and vitamin/mineral blends where bigger players are less dominant.

Strategic Partnerships The combination of independent family ownership, domestic leadership strength, and an established international agent network creates opportunities for strategic partnerships, co-marketing, and potential contract manufacturing or private-label collaborations with regional distributors.